Ultrasound ruler may cut repeat breast surgeries
NCT ID NCT07519668
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether using a special ultrasound ruler during breast-conserving surgery helps surgeons remove all cancer the first time. Researchers reviewed records from 273 patients who had this ultrasound-guided surgery. The goal was to see if it lowered the rate of incomplete tumor removal that would require a second surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, low-cost technique to reduce the need for repeat breast cancer surgeries.
- What could go wrong
- This is a retrospective review, not a controlled trial, so results may be influenced by other factors. The technique may not work for all tumor types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
273 people
The number who actually took part.
- Started
-
Jan 2020
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients who underwent breast-conserving mammosurgery using the standardized ultrasound ruler technique from 2020 to 2023, regardless of tumor biology, microcalcifications, focality, or primary chemotherapy.
- Ages
-
18 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age at least 18 years and no more than 80 years (inclusive) * Preoperatively histologically confirmed breast cancer, detectable by ultrasound * Unifocal to multifocal findings * Palpable and/or non-palpable findings * Indication for breast-conserving therapy (BCT) Exclusion Criteria: * Sonographically ambiguous findings * Multicentricity * Exclusion criteria for BCT * Status after neoadjuvant chemotherapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department for Women's Health
Tübingen, Baden-Wurttemberg, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?